{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T12:09:57Z","timestamp":1789560597646,"version":"build-2803163510"},"reference-count":51,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100016285","name":"WHO TDR","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016285","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cytokine"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.cyto.2026.157204","type":"journal-article","created":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T20:54:53Z","timestamp":1787604893000},"page":"157204","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["A STAT3-dominant signalling signature associated with immune suppression in human visceral leishmaniasis is reversed by checkpoint blockade and STAT3 inhibition"],"prefix":"10.1016","volume":"207","author":[{"given":"Peter Mac","family":"Asaga","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Axel","family":"Kroeger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philomena","family":"Airohuodion","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chukwuma","family":"Anyaike","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ishaku","family":"Bako","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Makpo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deborah","family":"Buba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dakul Anthony","family":"Danaan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.cyto.2026.157204_bb0005","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0035671","article-title":"Leishmaniasis worldwide and global estimates of its incidence","volume":"7","author":"Alvar","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.cyto.2026.157204_bb0010","first-page":"1","article-title":"Control of the leishmaniases","volume":"949","author":"World Health Organization","year":"2010","journal-title":"WHO Tech. Rep. Ser."},{"key":"10.1016\/j.cyto.2026.157204_bb0015","first-page":"286","article-title":"Parasitological and molecular detection of Leishmania species in dogs in Nigeria","volume":"44","author":"Igbinosa","year":"2020","journal-title":"J. Parasit. Dis."},{"issue":"2","key":"10.1016\/j.cyto.2026.157204_bb0020","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1517\/14656566.2015.973850","article-title":"An update on pharmacotherapy for leishmaniasis","volume":"16","author":"Sundar","year":"2015","journal-title":"Expert. Opin. Pharmacother."},{"key":"10.1016\/j.cyto.2026.157204_bb0025","first-page":"1","article-title":"Drug resistance and treatment failure in leishmaniasis","volume":"31","author":"Ponte-Sucre","year":"2017","journal-title":"Drug Resist. Updat."},{"issue":"4","key":"10.1016\/j.cyto.2026.157204_bb0030","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1084\/jem.189.4.741","article-title":"Macrophage microbicidal mechanisms in vivo: reactive nitrogen vs oxygen intermediates in killing of L. donovani","volume":"189","author":"Murray","year":"1999","journal-title":"J. Exp. Med."},{"issue":"3","key":"10.1016\/j.cyto.2026.157204_bb0035","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.it.2015.01.003","article-title":"Nitric oxide synthase in innate and adaptive immunity: an update","volume":"36","author":"Bogdan","year":"2015","journal-title":"Trends Immunol."},{"issue":"9","key":"10.1016\/j.cyto.2026.157204_bb0040","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.it.2007.07.004","article-title":"Interleukin-10 and the pathogenesis of human visceral leishmaniasis","volume":"28","author":"Nylen","year":"2007","journal-title":"Trends Immunol."},{"issue":"8","key":"10.1016\/j.cyto.2026.157204_bb0045","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1038\/nrmicro2608","article-title":"Leishmaniasis: complexity at the host\u2013pathogen interface","volume":"9","author":"Kaye","year":"2011","journal-title":"Nat. Rev. Microbiol."},{"issue":"7","key":"10.1016\/j.cyto.2026.157204_bb0050","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1093\/infdis\/jir461","article-title":"IL-10 neutralization promotes parasite clearance in splenic aspirate cells from patients with visceral leishmaniasis","volume":"204","author":"Gautam","year":"2011","journal-title":"J. Infect. Dis."},{"issue":"8","key":"10.1016\/j.cyto.2026.157204_bb0055","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1038\/nri3862","article-title":"Molecular and cellular insights into T cell exhaustion","volume":"15","author":"Wherry","year":"2015","journal-title":"Nat. Rev. Immunol."},{"issue":"3","key":"10.1016\/j.cyto.2026.157204_bb0060","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1038\/nri.2017.108","article-title":"The diverse functions of the PD1 inhibitory pathway","volume":"18","author":"Sharpe","year":"2018","journal-title":"Nat. Rev. Immunol."},{"issue":"2","key":"10.1016\/j.cyto.2026.157204_bb0065","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1093\/infdis\/jit401","article-title":"CD8 T cell exhaustion in human visceral leishmaniasis","volume":"209","author":"Gautam","year":"2014","journal-title":"J. Infect. Dis."},{"issue":"6","key":"10.1016\/j.cyto.2026.157204_bb0070","article-title":"PD1\/PDL-1 blockade improves IFN-\u03b3 production in visceral leishmaniasis","volume":"16","author":"Takele","year":"2022","journal-title":"PLoS Negl. Trop. Dis."},{"issue":"5","key":"10.1016\/j.cyto.2026.157204_bb0075","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1000431","article-title":"B7-H1 blockade increases survival of dysfunctional CD8+ T cells and confers protection against L. donovani infections","volume":"5","author":"Joshi","year":"2009","journal-title":"PLoS Pathog."},{"issue":"12","key":"10.1016\/j.cyto.2026.157204_bb0080","article-title":"Co-inhibitory receptors as markers of disease in visceral leishmaniasis","volume":"11","author":"Ademe","year":"2024","journal-title":"Open Forum Infect. Dis."},{"key":"10.1016\/j.cyto.2026.157204_bb0085","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2017.01492","article-title":"Immune checkpoint targets for host-directed therapy in leishmaniasis","volume":"8","author":"Kumar","year":"2017","journal-title":"Front. Immunol."},{"key":"10.1016\/j.cyto.2026.157204_bb0090","article-title":"T cell exhaustion in visceral leishmaniasis: the role of coinhibitory receptors","volume":"13","author":"Costa-Madeira","year":"2022","journal-title":"Front. Immunol."},{"issue":"3","key":"10.1016\/j.cyto.2026.157204_bb0095","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.clim.2006.01.017","article-title":"Elevated levels of interferon-\u03b3, interleukin-10, and interleukin-6 during active disease in Indian kala azar","volume":"119","author":"Ansari","year":"2006","journal-title":"Clin. Immunol."},{"issue":"4","key":"10.1016\/j.cyto.2026.157204_bb0100","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1172\/JCI116372","article-title":"In vivo cytokine profiles in patients with kala-azar","volume":"91","author":"Karp","year":"1993","journal-title":"J. Clin. Invest."},{"issue":"Suppl. 1","key":"10.1016\/j.cyto.2026.157204_bb0105","doi-asserted-by":"crossref","first-page":"S59","DOI":"10.1016\/S0035-9203(01)90219-6","article-title":"Leishmaniasis in Sudan: visceral leishmaniasis","volume":"95","author":"Zijlstra","year":"2001","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"issue":"3","key":"10.1016\/j.cyto.2026.157204_bb0110","first-page":"367","article-title":"Differential immune regulation of activated T cells between cutaneous and mucosal leishmaniasis as a model for pathogenesis","volume":"195","author":"Carvalho","year":"2007","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.cyto.2026.157204_bb0125","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1146\/annurev.immunol.19.1.683","article-title":"Interleukin-10 and the interleukin-10 receptor","volume":"19","author":"Moore","year":"2001","journal-title":"Annu. Rev. Immunol."},{"issue":"5","key":"10.1016\/j.cyto.2026.157204_bb0170","doi-asserted-by":"crossref","first-page":"2623","DOI":"10.4049\/jimmunol.178.5.2623","article-title":"The JAK-STAT signaling pathway: input and output integration","volume":"178","author":"Murray","year":"2007","journal-title":"J. Immunol."},{"issue":"4","key":"10.1016\/j.cyto.2026.157204_bb0175","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/j.immuni.2012.03.014","article-title":"JAK and STAT signaling molecules in immunoregulation and immune-mediated disease","volume":"36","author":"O\u2019Shea","year":"2012","journal-title":"Immunity"},{"issue":"5164","key":"10.1016\/j.cyto.2026.157204_bb0215","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1126\/science.8197455","article-title":"Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins","volume":"264","author":"Darnell","year":"1994","journal-title":"Science"},{"issue":"11","key":"10.1016\/j.cyto.2026.157204_bb0180","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1038\/nrc3818","article-title":"Revisiting STAT3 signalling in cancer: new and unexpected biological functions","volume":"14","author":"Yu","year":"2014","journal-title":"Nat. Rev. Cancer"},{"issue":"9","key":"10.1016\/j.cyto.2026.157204_bb0220","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1038\/nrm909","article-title":"Stats: transcriptional control and biological impact","volume":"3","author":"Levy","year":"2002","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"6","key":"10.1016\/j.cyto.2026.157204_bb0195","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1038\/ni931","article-title":"SOCS3 negatively regulates IL-6 signaling in vivo","volume":"4","author":"Croker","year":"2003","journal-title":"Nat. Immunol."},{"issue":"6","key":"10.1016\/j.cyto.2026.157204_bb0200","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1038\/nri2093","article-title":"SOCS proteins, cytokine signalling and immune regulation","volume":"7","author":"Yoshimura","year":"2007","journal-title":"Nat. Rev. Immunol."},{"issue":"1","key":"10.1016\/j.cyto.2026.157204_bb0225","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1042\/BJ20140712","article-title":"The molecular regulation of Janus kinase (JAK) activation","volume":"462","author":"Babon","year":"2014","journal-title":"Biochem. J."},{"issue":"1","key":"10.1016\/j.cyto.2026.157204_bb0205","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1053\/j.gastro.2006.04.025","article-title":"Deletion of the SOCS3 gene in liver parenchymal cells promotes hepatitis-induced hepatocarcinogenesis","volume":"131","author":"Ogata","year":"2006","journal-title":"Gastroenterology"},{"issue":"42","key":"10.1016\/j.cyto.2026.157204_bb0230","doi-asserted-by":"crossref","first-page":"6406","DOI":"10.1038\/sj.onc.1208788","article-title":"Methylation silencing of SOCS-3 promotes cell growth and migration by enhancing JAK\/STAT and FAK signalings in human hepatocellular carcinoma","volume":"24","author":"Niwa","year":"2005","journal-title":"Oncogene"},{"key":"10.1016\/j.cyto.2026.157204_bb0185","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.cyto.2017.03.018","article-title":"STAT3 in cancer: a double edged sword","volume":"98","author":"Avalle","year":"2017","journal-title":"Cytokine"},{"issue":"6","key":"10.1016\/j.cyto.2026.157204_bb0190","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1084\/jem.20112741","article-title":"Programmed cell death 1 forms negative costimulatory microclusters that directly inhibit T cell receptor signaling by recruiting phosphatase SHP2","volume":"209","author":"Yokosuka","year":"2012","journal-title":"J. Exp. Med."},{"issue":"6332","key":"10.1016\/j.cyto.2026.157204_bb0235","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1126\/science.aaf1292","article-title":"T cell costimulatory receptor CD28 is a primary target for PD-1-mediated inhibition","volume":"355","author":"Hui","year":"2017","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.cyto.2026.157204_bb0115","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1006165","article-title":"Transcriptional profiling in experimental visceral leishmaniasis reveals a broad splenic inflammatory environment","volume":"13","author":"Kong","year":"2017","journal-title":"PLoS Pathog."},{"issue":"3","key":"10.1016\/j.cyto.2026.157204_bb0240","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1128\/IAI.01320-07","article-title":"Comparison of the effects of Leishmania major or Leishmania donovani infection on macrophage gene expression","volume":"76","author":"Gregory","year":"2008","journal-title":"Infect. Immun."},{"issue":"7","key":"10.1016\/j.cyto.2026.157204_bb0130","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1084\/jem.192.7.1027","article-title":"Engagement of the PD-1 immunoinhibitory receptor by a novel B7 family member leads to negative regulation of lymphocyte activation","volume":"192","author":"Freeman","year":"2000","journal-title":"J. Exp. Med."},{"issue":"1","key":"10.1016\/j.cyto.2026.157204_bb0140","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0169496","article-title":"Splenic CD4+ T cells in progressive visceral leishmaniasis show a mixed exhaustion and senescence phenotype","volume":"12","author":"Medina-Colorado","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.cyto.2026.157204_bb0160","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.632667","article-title":"PD-1 blockade modulates functional activities of exhausted-like T cell in patients with cutaneous leishmaniasis","volume":"12","author":"Garcia de Moura","year":"2021","journal-title":"Front. Immunol."},{"issue":"11","key":"10.1016\/j.cyto.2026.157204_bb0165","doi-asserted-by":"crossref","first-page":"5542","DOI":"10.4049\/jimmunol.1301810","article-title":"PD-1-mediated T cell exhaustion during visceral leishmaniasis impairs phagocyte function","volume":"191","author":"Esch","year":"2013","journal-title":"J. Immunol."},{"issue":"11","key":"10.1016\/j.cyto.2026.157204_bb0245","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1016\/j.chembiol.2006.09.018","article-title":"Stattic, a small-molecule inhibitor of STAT3 activation and dimerization","volume":"13","author":"Schust","year":"2006","journal-title":"Chem. Biol."},{"key":"10.1016\/j.cyto.2026.157204_bb0250","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1146\/annurev-immunol-041015-055318","article-title":"CD8 T cell exhaustion during chronic viral infection and cancer","volume":"37","author":"McLane","year":"2019","journal-title":"Annu. Rev. Immunol."},{"issue":"6","key":"10.1016\/j.cyto.2026.157204_bb0120","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1093\/infdis\/jiu531","article-title":"IL-17A acts synergistically with IFN-\u03b3 to regulate CXCL10 expression during L. infantum infection","volume":"211","author":"Nascimento","year":"2015","journal-title":"J. Infect. Dis."},{"issue":"30","key":"10.1016\/j.cyto.2026.157204_bb0255","doi-asserted-by":"crossref","DOI":"10.18632\/oncotarget.9195","article-title":"Targeted inhibition of STATs and IRFs as a potential treatment strategy in cardiovascular disease","volume":"7","author":"Szelag","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.cyto.2026.157204_bb0260","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1186\/s12943-020-01258-7","article-title":"Targeting STAT3 in cancer immunotherapy","volume":"19","author":"Zou","year":"2020","journal-title":"Mol. Cancer"},{"issue":"4","key":"10.1016\/j.cyto.2026.157204_bb0150","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/S1473-3099(10)70026-8","article-title":"Immune reconstitution inflammatory syndrome in patients starting antiretroviral therapy","volume":"10","author":"M\u00fcller","year":"2010","journal-title":"Lancet Infect. Dis."},{"issue":"2","key":"10.1016\/j.cyto.2026.157204_bb0145","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1056\/NEJMra1703481","article-title":"Immune-related adverse events associated with immune checkpoint blockade","volume":"378","author":"Postow","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.cyto.2026.157204_bb0155","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1186\/s13071-016-1412-x","article-title":"Regulation of immunity during visceral Leishmania infection","volume":"9","author":"Rodrigues","year":"2016","journal-title":"Parasit. Vectors"},{"issue":"7","key":"10.1016\/j.cyto.2026.157204_bb0210","doi-asserted-by":"crossref","DOI":"10.1186\/gb-2002-3-7-research0034","article-title":"Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes","volume":"3","author":"Vandesompele","year":"2002","journal-title":"Genome Biol."}],"container-title":["Cytokine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043466626000992?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043466626000992?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T11:48:11Z","timestamp":1789559291000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043466626000992"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":51,"alternative-id":["S1043466626000992"],"URL":"https:\/\/doi.org\/10.1016\/j.cyto.2026.157204","relation":{},"ISSN":["1043-4666"],"issn-type":[{"value":"1043-4666","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A STAT3-dominant signalling signature associated with immune suppression in human visceral leishmaniasis is reversed by checkpoint blockade and STAT3 inhibition","name":"articletitle","label":"Article Title"},{"value":"Cytokine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cyto.2026.157204","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"157204"}}